YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
3.010
-0.135 (-4.29%)
At close: Jun 5, 2026, 4:00 PM EDT
3.020
+0.010 (0.33%)
After-hours: Jun 5, 2026, 4:37 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $211.66 million as of June 5, 2026. Its market cap has increased by 384.97% in one year.
Market Cap
211.66M
Enterprise Value
208.55M
1-Year Change
384.97%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $211.66M, an increase of 42.67%. That is a compound annual growth rate of 6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 211.66M | -75.31% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 221.33M |
| LENZ Therapeutics | 219.79M |
| Adagene | 219.36M |
| Foghorn Therapeutics | 219.00M |
| Camp4 Therapeutics | 213.42M |
| Cybin | 207.65M |
| Arcturus Therapeutics Holdings | 207.49M |
| ALX Oncology Holdings | 207.22M |